These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2572396)

  • 1. Further characterisation of the dopamine-inhibitory receptor in Helix and evidence for a noradrenaline-preferring receptor.
    Holden-Dye L; Walker RJ
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 93(2):413-9. PubMed ID: 2572396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.
    Evans AM; Green KL
    Br J Pharmacol; 1991 Dec; 104(4):787-92. PubMed ID: 1687366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 receptor activation depolarizes rat supraoptic neurones in hypothalamic explants.
    Yang CR; Bourque CW; Renaud LP
    J Physiol; 1991 Nov; 443():405-19. PubMed ID: 1688025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR; Bunney BS
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of both dopaminergic and alpha-adrenergic receptors in the hypomotility induced by dibenzoyl-6,7-ADTN.
    Sumners C; De Vries JB; Dijkstra D; Horn AS
    Eur J Pharmacol; 1981 Apr; 70(4):541-50. PubMed ID: 6113149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
    Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
    Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists.
    Jackisch R; Moll S; Feuerstein TJ; Hertting G
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):105-13. PubMed ID: 2995843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM; Barnes NM; Costall B; Naylor RJ
    Neuropharmacology; 1990 Apr; 29(4):327-36. PubMed ID: 1971430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine, noradrenaline, octopamine and tyrosine-hydroxylase in the gastropod Helix pomatia.
    Guthrie PB; Neuhoff V; Osborne NN
    Comp Biochem Physiol C Comp Pharmacol; 1975 Dec; 52(2):109-11. PubMed ID: 3363
    [No Abstract]   [Full Text] [Related]  

  • 12. Catecholaminergic activation of G-protein coupling in rat spinal cord: further evidence for the existence of dopamine and noradrenaline receptors in spinal grey and white matter.
    Venugopalan VV; Ghali Z; Sénécal J; Reader TA; Descarries L
    Brain Res; 2006 Jan; 1070(1):90-100. PubMed ID: 16423330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperpolarizing 'alpha 2'-adrenoceptors in rat sympathetic ganglia.
    Brown DA; Caulfield MP
    Br J Pharmacol; 1979 Mar; 65(3):435-45. PubMed ID: 218668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
    Carpéné C; Galitzky J; Fontana E; Atgié C; Lafontan M; Berlan M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):310-21. PubMed ID: 10344530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release.
    Gobert A; Rivet JM; Audinot V; Newman-Tancredi A; Cistarelli L; Millan MJ
    Neuroscience; 1998 May; 84(2):413-29. PubMed ID: 9539213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
    Godbout R; Mantz J; Pirot S; Glowinski J; Thierry AM
    J Pharmacol Exp Ther; 1991 Aug; 258(2):728-38. PubMed ID: 1865369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK; Jackson DM
    Brain Res; 1989 May; 487(2):267-77. PubMed ID: 2525062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterisation of the dopamine-sensitive adenylate cyclase in cockroach brain: evidence for a distinct dopamine receptor.
    Orr GL; Gole JW; Notman HJ; Downer RG
    Life Sci; 1987 Dec; 41(25):2705-15. PubMed ID: 2892104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.